Universal Biocon Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 9.90 M
as on 23-10-2024
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 M
as on 23-10-2024
- Revenue 1.11%
(FY 2023)
- Profit -27.95%
(FY 2023)
- Ebitda 1.29%
(FY 2023)
- Net Worth 12.14%
(FY 2023)
- Total Assets -8.78%
(FY 2023)
About Universal Biocon
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.90 M.
The company currently has active open charges totaling ₹8.00 M.
Vishwas Sondkar, Urmila Sondkar, and Shruti Sondkar serve as directors at the Company.
- CIN/LLPIN
U01122PN2013PTC148890
- Company No.
148890
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Universal Biocon Private Limited offer?
Universal Biocon Private Limited offers a wide range of products and services, including Insecticides and Pesticides, Biofungicides, Disposable Plate Making Machine, Die Plate Daters, Swimming Pool & Water Sport Goods, Swimming Pool Chemicals, Insecticides, Biopesticides, Fertilizer, Organic Fertilizers and Manure.
Who are the key members and board of directors at Universal Biocon?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishwas Sondkar  | Director | Current | |
| Urmila Sondkar | Director | 01-Dec-2022 | Current |
| Shruti Sondkar | Director | 27-Sep-2018 | Current |
Financial Performance of Universal Biocon.
Universal Biocon Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.11% increase. The company also saw a substantial fall in profitability, with a 27.95% decrease in profit. The company's net worth Soared by an impressive increase of 12.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Universal Biocon?
In 2023, Universal Biocon had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gm Biocides Private LimitedActive 13 years 8 monthsVishwas Sondkar, Urmila Sondkar and 1 more are mutual person
Molechem Life Sciences Private LimitedActive 11 years 7 monthsVishwas Sondkar and Urmila Sondkar are mutual person
Rajtoran Agro Producer Company LimitedActive 7 years 11 monthsVishwas Sondkar and Urmila Sondkar are mutual person
- Ecotech Pest Control Private LimitedActive 13 years 8 months
Vishwas Sondkar, Urmila Sondkar and 1 more are mutual person
- Sinhagad Tractors Private LimitedActive 7 years 5 months
Vishwas Sondkar and Urmila Sondkar are mutual person
- Kisan Dial Private LimitedActive 11 years 28 days
Vishwas Sondkar, Urmila Sondkar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 19 Sep 2014 | ₹8.00 M | Open |
How Many Employees Work at Universal Biocon?
Universal Biocon has a workforce of 27 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Universal Biocon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Universal Biocon's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
